Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialH. Miles Prince, M. D’Incan, Tatyana Feldman et al.|The Lancet|2017Cited by 580
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017Franz Trautinger, Robert Knobler, Johanna Eder et al.|European Journal of Cancer|2017Cited by 449
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic ModelJulia Scarisbrick, Henry K. Wong, H. Miles Prince et al.|Journal of Clinical Oncology|2015Cited by 419
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patientsJulia Scarisbrick, Andrew Bates, Pietro Quaglino et al.|British Journal of Dermatology|2018Cited by 235
Guidelines on the use of extracorporeal photopheresisRobert Knobler, Uwe Hillen, Gösta Berlin et al.|Journal of the European Academy of Dermatology and Venereology|2013Cited by 218